Invasive Fungal Disease in Patients with Myeloid Malignancies: A Retrospective Cohort Study of a Diagnostic-Driven Care Pathway Withholding Mould-Active Prophylaxis

Objectives: Patients receiving remission induction therapy for acute myeloid leukaemia (AML) are at high risk of developing invasive fungal disease (IFD). Newer therapies with targeted antileukemic agents and the emergence of azole resistance pose a challenge to the strategy of primary antifungal pr...

Descripción completa

Detalles Bibliográficos
Autores principales: De Kort, Elizabeth A., Buil, Jochem B., Schalekamp, Steven, Schaefer-Prokop, Cornelia, Verweij, Paul E., Schaap, Nicolaas P. M., Blijlevens, Nicole M. A., Van der Velden, Walter J. F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504036/
https://www.ncbi.nlm.nih.gov/pubmed/36135650
http://dx.doi.org/10.3390/jof8090925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504036/
https://www.ncbi.nlm.nih.gov/pubmed/36135650
http://dx.doi.org/10.3390/jof8090925

Ejemplares similares